MLTX holder plans sale of 150,000 Class A shares

Jerucon Beratungsgesellschaft mbH filed a Form 144 notice covering the proposed sale of 150,000 Class A Ordinary shares of MLTX.

Rhea-AI Filing Summary

Jerucon Beratungsgesellschaft mbH filed a Form 144 notice covering the proposed sale of 150,000 Class A Ordinary shares of MLTX. The shares are to be sold through UBS Financial Services, Inc. on or after 07/15/2026 on the Nasdaq market for an aggregate value of 2916000.00.

The notice also reports that Jerucon Beratungsgesellschaft mbH has recently sold 50,000 common shares on each of 06/15/2026, 06/16/2026, and 06/17/2026, for aggregate proceeds of 944280.00, 934995.00, and 971325.00, respectively.

Key Figures

Proposed shares for sale: 150000 shares Proposed sale value: 2916000.00 Proposed sale date: 07/15/2026 +3 more

6 metrics

Proposed shares for sale 150000 shares Class A Ordinary shares of MLTX to be sold through UBS Financial Services, Inc.

Proposed sale value 2916000.00 Aggregate value in dollars for proposed sale of 150000 Class A Ordinary shares

Proposed sale date 07/15/2026 Planned sale date for Class A Ordinary shares on Nasdaq

Shares sold 06/15/2026 50000 shares Common shares sold by Jerucon Beratungsgesellschaft mbH for 944280.00 aggregate

Shares sold 06/16/2026 50000 shares Common shares sold by Jerucon Beratungsgesellschaft mbH for 934995.00 aggregate

Shares sold 06/17/2026 50000 shares Common shares sold by Jerucon Beratungsgesellschaft mbH for 971325.00 aggregate

Key Terms

Class A Ordinary, Securities To Be Sold, Securities Sold During The Past 3 Months

3 terms

Class A Ordinary financial

"Class A Ordinary | UBS Financial Services, Inc. Eleven Madison Avenue 4th Floor"

Securities To Be Sold regulatory

"144: Securities To Be Sold | Class A Ordinary | UBS Financial Services, Inc."

Securities Sold During The Past 3 Months regulatory

"144: Securities Sold During The Past 3 Months | Jerucon Beratungsgesellschaft mbH"

FAQ

AI-generated questions and answers. How Rhea-AI works. Not financial advice.

What stock sale does the MLTX Form 144 filing disclose?

The filing discloses a proposed sale of 150,000 Class A Ordinary shares of MLTX. These shares are to be sold through UBS Financial Services, Inc. on or after 07/15/2026 on the Nasdaq market for an aggregate value of 2916000.00.

Who is the selling security holder in the MLTX Form 144 filing?

The selling security holder is Jerucon Beratungsgesellschaft mbH, listed with an address at Dorfstrasse 29, Zug, 6300. This entity is identified in connection with both the proposed sale and the common share sales reported during the past three months.

When is the proposed sale of MLTX shares expected to occur?

The proposed sale of MLTX Class A Ordinary shares is dated for 07/15/2026. The Form 144 indicates these shares are intended to be sold on the Nasdaq market through UBS Financial Services, Inc., subject to market conditions and applicable regulatory requirements.

What MLTX shares were sold in the past three months according to this filing?

Jerucon Beratungsgesellschaft mbH sold 50,000 common shares of MLTX on each of 06/15/2026, 06/16/2026, and 06/17/2026, for aggregate amounts of 944280.00, 934995.00, and 971325.00, respectively, as reported in the Form 144.

Through which broker will the proposed MLTX share sale be executed?

The proposed sale of 150,000 Class A Ordinary shares of MLTX will be executed through UBS Financial Services, Inc., located at Eleven Madison Avenue, 4th Floor, New York, NY 10010, as indicated in the Form 144 securities information section.

AI-generated analysis. How Rhea-AI works. Not financial advice.

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google Not now

Accepted by SEC EDGAR 07/15/2026 - 04:46 PM EDT Learn about SEC filing dates

Form 144 Filer Information	UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 144 NOTICE OF PROPOSED SALE OF SECURITIES PURSUANT TO RULE 144 UNDER THE SECURITIES ACT OF 1933
FORM 144

144: Filer Information

Filer CIK	0001920553
Filer CCC	XXXXXXXX
Is this a LIVE or TEST Filing?	LIVE TEST
Submission Contact Information
Name
Phone
E-Mail Address

144: Issuer Information

Name of Issuer	MoonLake Immunotherapeutics
SEC File Number	001-39630
Address of Issuer	DORFSTRASSE 29 ZUG SWITZERLAND 6300
Phone	41 41 510 8022
Name of Person for Whose Account the Securities are To Be Sold	Reich Kristian
See the definition of "person" in paragraph (a) of Rule 144. Information is to be given not only as to the person for whose account the securities are to be sold but also as to all other persons included in that definition. In addition, information shall be given as to sales by all persons whose sales are required by paragraph (e) of Rule 144 to be aggregated with sales for the account of the person filing this notice.
Relationship to Issuer	Officer

144: Securities Information

Title of the Class of Securities To Be Sold	Name and Address of the Broker	Number of Shares or Other Units To Be Sold	Aggregate Market Value	Number of Shares or Other Units Outstanding	Approximate Date of Sale	Name the Securities Exchange
Class A Ordinary	UBS Financial Services, Inc. Eleven Madison Avenue 4th Floor New York NY 10010	150000	2916000.00	73615396	07/15/2026	Nasdaq

Furnish the following information with respect to the acquisition of the securities to be sold and with respect to the payment of all or any part of the purchase price or other consideration therefor:

144: Securities To Be Sold

Title of the Class	Date you Acquired	Nature of Acquisition Transaction	Name of Person from Whom Acquired	Is this a Gift?	Date Donor Acquired	Amount of Securities Acquired	Date of Payment	Nature of Payment *
Class A Ordinary	04/05/2023	Exchange of shares	Issuer			150000	04/05/2023	NA

* If the securities were purchased and full payment therefor was not made in cash at the time of purchase, explain in the table or in a note thereto the nature of the consideration given. If the consideration consisted of any note or other obligation, or if payment was made in installments describe the arrangement and state when the note or other obligation was discharged in full or the last installment paid.

Furnish the following information as to all securities of the issuer sold during the past 3 months by the person for whose account the securities are to be sold.

144: Securities Sold During The Past 3 Months

Name and Address of Seller	Title of Securities Sold	Date of Sale	Amount of Securities Sold	Gross Proceeds
Jerucon Beratungsgesellschaft mbH Dorfstrasse 29 Zug V8 6300	Common	06/16/2026	50000	934995.00
Jerucon Beratungsgesellschaft mbH Dorfstrasse 29 Zug V8 6300	Common	06/17/2026	50000	971325.00
Jerucon Beratungsgesellschaft mbH Dorfstrasse 29 Zug V8 6300	Common	06/15/2026	50000	944280.00

144: Remarks and Signature

Remarks	150,000 shares represented in this filing are being sold under Jerucon Beratungsgesellschaft mbH
Date of Notice	07/15/2026
Date of Plan Adoption or Giving of Instruction, If Relying on Rule 10b5-1	03/10/2026
ATTENTION:
The person for whose account the securities to which this notice relates are to be sold hereby represents by signing this notice that he does not know any material adverse information in regard to the current and prospective operations of the Issuer of the securities to be sold which has not been publicly disclosed. If such person has adopted a written trading plan or given trading instructions to satisfy Rule 10b5-1 under the Exchange Act, by signing the form and indicating the date that the plan was adopted or the instruction given, that person makes such representation as of the plan adoption or instruction date.
Signature	/s/ UBS Financial Services Inc, as attorney-in-fact for Dr.Kristian Reich
ATTENTION: Intentional misstatements or omission of facts constitute Federal Criminal Violations (See 18 U.S.C. 1001)